Three Mathys & Squire Partners, Anna Gregson, Dani Kramer, and Martin MacLean, have been recognised in the 2026 edition of IAM Strategy 300 Global Leaders.
The guide acknowledges those that have showcased their strategic expertise in IP, which has been recognised by clients and colleagues across a range of sectors. Those that have been selected to feature in the prestigious directory have earnt their place through their consistently exceptional work and industry knowledge.
IAM says: Anna Gregson is a recognised leader for strategic IP advisory, leveraging her deep technical expertise in biotechnology to deliver specialised guidance across diverse sectors, including plant biotechnology and diagnostics. Her approach ensures that clients’ IP portfolios are not only technically sound but also commercially resilient.
IAM says: Dani Kramer is a seasoned expert in internet television, software, and AI, with specialised knowledge in semiconductor devices and communication technologies. His career includes securing key patents in the internet television space and managing a portfolio of standard-essential HEVC MPEG patents, underscoring his impactful contributions to this field.
IAM says: Martin MacLean is a distinguished legal practitioner with a robust background in biotechnology and intellectual property. With over 100 EPO hearings under his belt and a remarkable success rate of approximately 90%, he excels in areas such as protein therapeutics, antibodies, and vaccines.
We would like to express our thanks to every client, contact, and peer who dedicated their time to engage in the research process.
The full 2026 edition of the guide is available here.
